Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 4Pain 4Neoplasms 4Nausea 3Pancreatic Neoplasms 2Cancer Pain 2Breast Neoplasms 2Taste Disorders 1Parasomnias 1Olfaction Disorders 1Marijuana Abuse 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1

Interventions

miraculin protein, Synsepalum dulcificum 1Nutrition Assessment 1Low-Level Light Therapy 1Ice 1Dronabinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Taste Disorders × Dronabinol × Clear all
NCT00316563 2010-02-09

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

AHS Cancer Control Alberta

Phase 2 Completed
80 enrolled

Anorexia, Olfaction Disorders, Neoplasms, Taste Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡